Cytogel Pharma Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Latest Deal Amount
-
$16M
- Investors
-
5
Cytogel Pharma General Information
Description
Operator of a biopharmaceutical company intended to discover and develop safe and innovative treatments for moderate to severe pain. The company offers drug discovery technologies and therapeutic drug candidates focused on pain management, enabling patients and healthcare providers to access treatments intended to improve pain relief and treatment outcomes.
Contact Information
Website
www.cytogelpharma.comCorporate Office
- 3 Thorndal Circle
- Darien, CT 06820
- United States
Corporate Office
- 3 Thorndal Circle
- Darien, CT 06820
- United States
Cytogel Pharma Timeline
Cytogel Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 01-Dec-2025 | $16M | In Progress | Clinical Trials - Phase 2 | ||
| 9. Later Stage VC | 23-Dec-2025 | Completed | Clinical Trials - Phase 2 | |||
| 8. Later Stage VC | 03-May-2024 | Completed | Clinical Trials - General | |||
| 7. Later Stage VC | 11-Oct-2024 | Completed | Clinical Trials - General | |||
| 6. Later Stage VC | 20-May-2021 | Completed | Clinical Trials - General | |||
| 5. Later Stage VC | 06-Jan-2015 | Completed | Clinical Trials - General | |||
| 4. Grant | 30-Nov-2010 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC | 12-May-2010 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series B) | 05-Sep-2008 | $1.19M | $3.9M | Completed | Clinical Trials - General | |
| 1. Early Stage VC | 10-Oct-2006 | $2.71M | $2.71M | Completed | Clinical Trials - General |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Cytogel Pharma Comparisons
Industry
Financing
Details
Cytogel Pharma Competitors (26)
One of Cytogel Pharma’s 26 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Neuraxpharm | Private Equity-Backed | Barcelona, Spain | ||||
| Bluefish Pharmaceuticals | Private Equity-Backed | Stockholm, Sweden | ||||
| Centrose | Venture Capital-Backed | Madison, WI |
Cytogel Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cytogel Pharma Patents
Cytogel Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018375087-A1 | Novel analgesic pharmaceutical formulations and uses thereof | Active | 30-Nov-2017 | ||
| AU-2018375087-B2 | Novel analgesic pharmaceutical formulations and uses thereof | Active | 30-Nov-2017 | ||
| CA-3083190-A1 | Novel analgesic pharmaceutical formulations and uses thereof | Active | 30-Nov-2017 | ||
| EP-3716948-A1 | Novel analgesic pharmaceutical formulations and uses thereof | Active | 30-Nov-2017 | ||
| EP-3716948-A4 | Novel analgesic pharmaceutical formulations and uses thereof | Active | 30-Nov-2017 | A61P29/00 |
Cytogel Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cytogel Pharma Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| New Ground Ventures | Venture Capital | Minority | ||
| Centripetal Capital Partners | Venture Capital | Minority | ||
| Cytogel Venture | Lender/Debt Provider | Minority | ||
| Westway Capital | Venture Capital | Minority |
Cytogel Pharma FAQs
-
When was Cytogel Pharma founded?
Cytogel Pharma was founded in 2006.
-
Where is Cytogel Pharma headquartered?
Cytogel Pharma is headquartered in Darien, CT.
-
What is the size of Cytogel Pharma?
Cytogel Pharma has 6 total employees.
-
What industry is Cytogel Pharma in?
Cytogel Pharma’s primary industry is Biotechnology.
-
Is Cytogel Pharma a private or public company?
Cytogel Pharma is a Private company.
-
What is the current valuation of Cytogel Pharma?
The current valuation of Cytogel Pharma is .
-
What is Cytogel Pharma’s current revenue?
The current revenue for Cytogel Pharma is .
-
How much funding has Cytogel Pharma raised over time?
Cytogel Pharma has raised $32.8M.
-
Who are Cytogel Pharma’s investors?
, New Ground Ventures, Centripetal Capital Partners, Cytogel Venture, and Westway Capital have invested in Cytogel Pharma.
-
Who are Cytogel Pharma’s competitors?
Pfizer (Vienna), Pfizer Pakistan, Neuraxpharm, Bluefish Pharmaceuticals, and Centrose are some of the 26 competitors of Cytogel Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
